Abstract
Prion pathologies are characterized by the conformational conversion of the cellular prion protein (PrPC) into a pathological infectious isoform, known as PrPSc. The latter acquires different abnormal conformations, which are associated with specific pathological phenotypes. Recent evidence suggests that prions adapt their conformation to changes in the context of replication. This phenomenon is known as either prion selection or adaptation, where distinct conformations of PrPSc with higher propensity to propagate in the new environment prevail over the others. Here, we show that a synthetically generated prion isolate, previously subjected to protein misfolding cyclic amplification (PMCA) and then injected in animals, is able to change its biochemical and biophysical properties according to the context of replication. In particular, in second transmission passage in vivo, two different prion isolates were found: one characterized by a predominance of the monoglycosylated band (PrPSc-M) and the other characterized by a predominance of the diglycosylated one (PrPSc-D). Neuropathological, biochemical, and biophysical assays confirmed that these PrPSc possess distinctive characteristics. Finally, PMCA analysis of PrPSc-M and PrPSc-D generated PrPSc (PrPSc-PMCA) whose biophysical properties were different from those of both inocula, suggesting that PMCA selectively amplified a third PrPSc isolate. Taken together, these results indicate that the context of replication plays a pivotal role in either prion selection or adaptation. By exploiting the ability of PMCA to mimic the process of prion replication in vitro, it might be possible to assess how changes in the replication environment influence the phenomenon of prion selection and adaptation.
Similar content being viewed by others
References
McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35(1):57–62
Tanaka M, Chien P, Naber N, Cooke R, Weissman JS (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428(6980):323–328
Bartz JC (2016) Prion strain diversity. Cold Spring Harb Perspect Med 6(12)
Dickinson AG, Meikle VM (1971) Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet 112(1):73–79
Carp RI, Callahan SM, Sersen EA, Moretz RC (1984) Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination. Intervirology 21(2):61–69
Fraser H (1993) Diversity in the neuropathology of scrapie-like diseases in animals. Br Med Bull 49(4):792–809
Fraser H, Dickinson AG (1968) The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78(3):301–311
Khalili-Shirazi A, Summers L, Linehan J, Mallinson G, Anstee D, Hawke S, Jackson GS, Collinge J (2005) PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol 86(Pt 9):2635–2644
Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB et al (2002) A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34(6):921–932
Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4(10):1157–1165
Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 273(48):32230–32235
Makarava N, Savtchenko R, Baskakov IV (2013) Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification. J Biol Chem 288(1):33–41
Morales R, Abid K, Soto C (2007) The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 1772(6):681–691
Bartz JC, Bessen RA, McKenzie D, Marsh RF, Aiken JM (2000) Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74(12):5542–5547
Bessen RA, Marsh RF (1992) Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73(Pt 2):329–334
Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68(12):7859–7868
Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66(4):2096–2101
Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB (2004) Synthetic mammalian prions. Science 305(5684):673–676
Colby DW, Giles K, Legname G, Wille H, Baskakov IV, DeArmond SJ, Prusiner SB (2009) Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A 106(48):20417–20422
Jeffrey M, McGovern G, Makarava N, Gonzalez L, Kim YS, Rohwer RG, Baskakov IV (2014) Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies. Neuropathol Appl Neurobiol 40(3):296–310
Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV (2012) Stabilization of a prion strain of synthetic origin requires multiple serial passages. J Biol Chem 287(36):30205–30214
Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV (2010) Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119(2):177–187
Moda F, Le TN, Aulic S, Bistaffa E, Campagnani I, Virgilio T, Indaco A, Palamara L et al (2015) Synthetic prions with novel strain-specified properties. PLoS Pathog 11(12):e1005354
Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411(6839):810–813
Saa P, Castilla J, Soto C (2006) Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281(46):35245–35252
Bieschke J, Weber P, Sarafoff N, Beekes M, Giese A, Kretzschmar H (2004) Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci U S A 101(33):12207–12211
Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA et al (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5(3):211–212
Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, Soto C (2008) Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134(5):757–768
Barria MA, Telling GC, Gambetti P, Mastrianni JA, Soto C (2011) Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions. J Biol Chem 286(9):7490–7495
Chianini F, Fernandez-Borges N, Vidal E, Gibbard L, Pintado B, de Castro J, Priola SA, Hamilton S et al (2012) Rabbits are not resistant to prion infection. Proc Natl Acad Sci U S A 109(13):5080–5085
Gonzalez-Montalban N, Lee YJ, Makarava N, Savtchenko R, Baskakov IV (2013) Changes in prion replication environment cause prion strain mutation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 27(9):3702–3710
Mahal SP, Browning S, Li J, Suponitsky-Kroyter I, Weissmann C (2010) Transfer of a prion strain to different hosts leads to emergence of strain variants. Proc Natl Acad Sci U S A 107(52):22653–22658
Vascellari S, Orru CD, Hughson AG, King D, Barron R, Wilham JM, Baron GS, Race B et al (2012) Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. PLoS One 7(11):e48969
Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, Bartz JC (2011) The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog 7(3):e1001317
Bett C, Joshi-Barr S, Lucero M, Trejo M, Liberski P, Kelly JW, Masliah E, Sigurdson CJ (2012) Biochemical properties of highly neuroinvasive prion strains. PLoS Pathog 8(2):e1002522
Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 103(50):19105–19110
Hannaoui S, Amidian S, Cheng YC, Duque Velasquez C, Dorosh L, Law S, Telling G, Stepanova M et al (2017) Destabilizing polymorphism in cervid prion protein hydrophobic core determines prion conformation and conversion efficiency. PLoS Pathog 13(8):e1006553
Makarava N, Baskakov IV (2012) Genesis of tramsmissible protein states via deformed templating. Prion 6(3):252–255
Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Ostapchenko VG, Budka H, Rohwer RG, Baskakov IV (2012) A new mechanism for transmissible prion diseases. J Neurosci 32(21):7345–7355
Lloyd SE, Linehan JM, Desbruslais M, Joiner S, Buckell J, Brandner S, Wadsworth JD, Collinge J (2004) Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol 85(Pt 8):2471–2478
Le Dur A, Lai TL, Stinnakre MG, Laisne A, Chenais N, Rakotobe S, Passet B, Reine F et al (2017) Divergent prion strain evolution driven by PrP(C) expression level in transgenic mice. Nat Commun 8:14170
Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73(7):1339–1347
Goold R, McKinnon C, Tabrizi SJ (2015) Prion degradation pathways: potential for therapeutic intervention. Mol Cell Neurosci 66(Pt A):12–20
McKinnon C, Goold R, Andre R, Devoy A, Ortega Z, Moonga J, Linehan JM, Brandner S et al (2016) Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system. Acta Neuropathol 131(3):411–425
Weissmann C, Li J, Mahal SP, Browning S (2011) Prions on the move. EMBO Rep 12(11):1109–1117
Yim YI, Park BC, Yadavalli R, Zhao X, Eisenberg E, Greene LE (2015) The multivesicular body is the major internal site of prion conversion. J Cell Sci 128(7):1434–1443
Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, Baskakov IV (2011) Highly efficient protein misfolding cyclic amplification. PLoS Pathog 7(2):e1001277
Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferriere F et al (2013) Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification. MBio 5(1):e00829–e00813
Shikiya RA, Bartz JC (2011) In vitro generation of high-titer prions. J Virol 85(24):13439–13442
Castilla J, Saa P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121(2):195–206
Fernandez-Borges N, Di Bari MA, Erana H, Sanchez-Martin M, Pirisinu L, Parra B, Elezgarai SR, Vanni I et al (2017) Cofactors influence the biological properties of infectious recombinant prions. Acta Neuropathol
Ghaemmaghami S, Ahn M, Lessard P, Giles K, Legname G, DeArmond SJ, Prusiner SB (2009) Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog 5(11):e1000673
Bian J, Kang HE, Telling GC (2014) Quinacrine promotes replication and conformational mutation of chronic wasting disease prions. Proc Natl Acad Sci U S A 111(16):6028–6033
Acknowledgements
The authors wish to thank Associazione Italiana Encefalopatie da Prioni (A.I.En.P.).
Funding
This work was supported/partially supported by the Italian Ministry of Health (GR-2013-02355724 and RC) to FM, the Italian Ministry of Health to FT, and the International School for Advanced Studies (SISSA) intramural funding to GL.
Author information
Authors and Affiliations
Contributions
EB, FM, and GL designed the experiments and EB, TV, IC, CMGDL, MR, and GS performed the practical work. TV and IC performed the animal inoculations. EB, FM, GG, FT, and GL wrote and revised the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
The study, including its Ethics aspects, was approved by the Italian Ministry of Health (Permit Number, NP-02-14).
Conflict of Interest
The authors declare that there are no conflicts of interest.
Electronic Supplementary Material
ESM 1
Biochemical characterization of PrPSc in eyes and spleen of animals with PrPSc-M and PrPSc-D. (JPG 210 kb)
ESM 2
PMCA analysis of PrPSc-M and PrPSc-D spleen-derived PrPSc. (JPG 188 kb)
ESM 3
ThS staining of frontal cortex of mice with PrPSc-M and PrPSc-D. (JPG 352 kb)
ESM 4
PMCA amplification of serial dilutions of PrPSc-M and PrPSc-D. PrPSc-M and PrPSc-D were serially diluted in normal mouse brain homogenates and subjected to 2 serial rounds of amplification by means of PMCA. All amplified samples showed a PrPSc characterized by a prevalence of the diglycosylated isoform of the protein. (JPG 768 kb)
ESM 5
RT-QuIC assay of PrPSc-M and PrPSc-D isolates. (A) Representative kinetic curves of recombinant mouse PrP (recPrP) seeded with PrPSc-M and PrPSc-D and PrPSc-PMCA. (B) Analysis of the slope of PrPSc-M and PrPSc-D and PrPSc-PMCA aggregation kinetic curves. (* p<0.05, ** p<0.01) (C) Analysis of the slope of RML and RML-PMCA aggregation kinetic curves. (JPG 608 kb)
Rights and permissions
About this article
Cite this article
Bistaffa, E., Moda, F., Virgilio, T. et al. Synthetic Prion Selection and Adaptation. Mol Neurobiol 56, 2978–2989 (2019). https://doi.org/10.1007/s12035-018-1279-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1279-2